Business
E-Home Household Service Holdings Limited to Explore Potential Monkeypox Treatment Programs via Its Subsidiary Zhongrun (Fujian) Pharmaceutical Co., Ltd.
FUZHOU, China, July 27, 2022 (GLOBE NEWSWIRE) -- E-Home Household Service Holdings Limited (NASDAQ: EJH) (the “Company” or “E-Home”), a provider of integrated
About this update from E-home Household Service Holdings Limited
[{"type":"text","content":"FUZHOU, China, July 27, 2022 (GLOBE NEWSWIRE) -- E-Home Household Service Holdings Limited (NASDAQ: EJH) (the “Company” or “E-Home”), a provider of integrated household services in China, today announced that it has begun a provisional investigation into feasible treatment applications of traditional Chinese medicine for Monkeypox via its recently acquired majority ownership in Zhongrun (Fujian) Pharmaceutical Co., Ltd. (“Zhongrun”), a leading medicine and personal care products operator in China. Founded in 2017 with RMB100 million registered capital, Zhongrun operates as a drug wholesaler and logistics distributor specializing in all kinds of traditional Chinese medicines, antibiotics, dietary supplements and medical devices. Some of the ingredients provided by Zhongrun have been used for thousands of years as key herbs in traditional Chinese medicine, which may have health effects, such as lowering blood pressure, alleviating cold and flu symptoms, reducing pain and enhancing immune system against contagious diseases. While monkeypox is rarely fatal, it shares similar symptoms to the smallpox virus: fever, headaches, muscle aches and exhaustion to name a few. Though there are currently no treatments specifically for monkeypox virus infections, it is genetically similar to smallpox. According to the \"Monkeypox Treatment Guidelines 2022 Edition\" developed by China’s National Heath Commission and the National Administration of Traditional Chinese Medicine in June 2022, the proposed traditional Chinese medicine treatment for monkeypox requires that treatment can be implemented based on traditional Chinese medicine principles of evidence-based diagnosis, which potentially opening the door for viable, holistic treatment programs utilizing proven traditional Chinese medicines in China. Mr. Wenshan Xie, Chairman and CEO of E-Home, commented: “Traditional Chinese medicines have been relied upon for thousands of years and have the capacity to treat a large variety of illnesses. I believe we have an important opportunity to leverage Zhongrun’s strength in the area of traditional Chinese medicine to uncover potential treatment options for the monkeypox virus. We are looking forward to sharing our findings in the near future.” About E-Home Household Service Holdings Limited Established in 2014, E-Home Household Service Holdings Limited ...